Togo

Pharmacovigilance in Togo is coordinated by the Ministry of Health through the Directorate responsible for pharmacy, medicines and laboratories and the national pharmacovigilance system. Official national arrangements describe a reporting network for adverse drug reactions and adverse events following immunisation, with reports collected through health facilities and national pharmacovigilance focal points. Togo has been a full member of the WHO Programme for International Drug Monitoring since 2007. Publicly accessible official sources reviewed for this guide do not provide a complete current industry GVP guideline specifying a local QPPV, PSMF, routine PSUR/PBRER timetable, RMP format or pharmacovigilance-inspection programme. Marketing-authorisation holders should nevertheless maintain a documented safety system, promptly forward reportable local cases through the national channels and comply with any conditions imposed during registration or requested by the Ministry. BAUPHARMA supporting resources (operational context only, not national regulatory evidence): Effective Signal Management in Pharmacovigilance.